TELA Bio, Inc. Common Stock (TELA) is a publicly traded Healthcare sector company. As of May 21, 2026, TELA trades at $0.95 with a market cap of $37.16M and a P/E ratio of -1.23. TELA moved +12.15% today. Year to date, TELA is -13.73%; over the trailing twelve months it is -28.65%. Its 52-week range spans $0.50 to $3.26. Analyst consensus is strong buy with an average price target of $2.00. Rallies surfaces TELA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TELA Bio, Inc. Common Stock (TELA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TELA moved +12.15% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $0.95 |
| Market Cap | $37.16M |
| P/E Ratio | -1.23 |
| EPS | $-0.79 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.26 |
| 52-Week Low | $0.50 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $80.81M |
| Net Income | $-39.84M |
| Gross Margin | 67.25% |
4 analysts cover TELA: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $2.00.